This article outlines the burden of pneumococcal disease and the basis for
immunity to pneumococcal infections, and discusses the properties of polysa
ccharide-protein conjugate vaccines. Also, the immunogenicity and safety of
specific pneumococcal conjugate vaccines that have been studied in infants
are reviewed.